1 |
Balan, K.V., Wang, Y., Chen, S.W., Pantazis, P., Wyche, J.H., and Han, Z. (2006). Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition. Biochem. Pharmacol. 72, 566-572
DOI
ScienceOn
|
2 |
Cheng, J.Q., Altomare, D.A., Klein, M.A., Lee, W.C., Kruh, G.D., Lissy, N.A., and Testa, J.R. (1997). Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14, 2793-2801
DOI
ScienceOn
|
3 |
Dempsey, P.W., Doyle, S.E., He, J.Q., and Cheng, G. (2003). The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14, 193-209
DOI
ScienceOn
|
4 |
Diem, R., Meyer, R., Weishaupt, J.H., and Bahr, M. (2001). Reduction of potassium currents and phosphatidylinositol 3-kinasedependent AKT phosphorylation by tumor necrosis factor- (alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. J. Neurosci. 21, 2058-2066
DOI
|
5 |
Ferguson, A.T., and Davidson, N.E. (1997). Regulation estrogen receptor alpha function in breast cancer. Crit. Rev. Oncog. 8, 29-46
DOI
ScienceOn
|
6 |
Kawaguchi, W., Itamochi, H., Kigawa, J., Kanamori, Y., Oishi, T., Shimada, M., Sato, S., Shimogai, R., Sato, S., and Terakawa, N. (2007). Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3′-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. Cancer Sci. 98, 2002-2008
DOI
ScienceOn
|
7 |
Marsaud, V., Gougelet, A., Maillard, S., and Renoir, J. (2003). Various phosphorylation pathways, depending on agonist and antagonist binding to endogeneous estrogen receptor (ER ), differentially affect ER extractability, proteasome-mediated stability, and transcriptional activity in breast cancer cells. Mol. Endocrinol. 17, 2013-2027
DOI
ScienceOn
|
8 |
Martin, M.B., Franke, T.F., Stoica, G.E., Chambon, P., Katzenellenbogen, B.S., Stoica, B.A., McLemore, M.S., Olivo, S.E., and Stoica, A. (2000). A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141, 4503-4511
DOI
ScienceOn
|
9 |
Nawaz, Z., Lonard, D.M., Dennis, A.P., Smith, C.L., and O'Malley, B.W. (1999). Proteasome-dependent degradation of human estrogen receptor. Proc. Natl. Acad. Sci. USA 96, 1858-1862
|
10 |
Simoncini, T., Hafezi-Moghadam, A., Brazil, D.P., Ley, K., Chin, W.W., and Liao, J.K. (2000). Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541
DOI
ScienceOn
|
11 |
Takao, T., Kumagai, C., Hisakawa, N., Matsumoto, R., and Hashimoto, K. (2005). Effect of 17 -estradiol on tumor necrosis factor- -induced cytotoxicity in human peripheral T lymphocytes. J. Endocrinol. 184, 191-197
DOI
ScienceOn
|
12 |
Zhang, Q.S., Maddock, D.A., Chen, J.P., Heo, S., Chiu, C., Lai, D., Souza, K., Mehta, S., and Wan, Y.S. (2001). Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int. J. Oncol. 19, 1057-1061
|
13 |
Lau, K.M., Mok, S.C., and Ho, S.M. (1999). Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. USA 96, 5722-5727
|
14 |
Osawa, Y., Nagaki, M., Banno, Y., Brenner, D.A., Nozawa, Y., Moriwaki, H., and Nakashima, S. (2003). Expression of the NFkappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation. J. Immunol. 170, 4053-4060
DOI
|
15 |
Sonoda, Y., Watanabe, S., Matsumoto, Y., Aizu-Yokota, E., and Kasahara, T. (1999). FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J. Biol. Chem. 274, 10566-10570
DOI
ScienceOn
|
16 |
Garg, A.K., and Aggarwal, B.B. (2002). Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39, 509-517
DOI
ScienceOn
|
17 |
Le May, C., Chu, K., Hu, M., Ortega, C.S., Simpson, E.R., Korach, K.S., Tsai, M.J., and Mauvais-Jarvis, F. (2006). Estrogens protect pancreatic -cells from apoptosis and prevent insulindeficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. USA 103, 9232-9237
|
18 |
Burow, M.E., Tang, Y., Collins-Burow, B.M., Krajewski, S., Reed, J.C., McLachlan, J.A., and Beckman, B.S. (1999). Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis 20, 2057-2061
DOI
ScienceOn
|
19 |
Cantrell, D.A. (2001). Phosphoinositide 3-kinase signaling pathways. J. Cell Sci. 114, 1439-1445
|
20 |
Lu, D., Huang, J., and Basu, A. (2006). Protein kinase Ce activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor- -induced cell death. J. Biol. Chem. 281, 22799-22807
DOI
ScienceOn
|
21 |
Wang, C.Y., Mayo, M.W., and Baldwin, Jr. A.S. (1996). TNF- and cancer therapy-induced apoptosis; potentiation by inhibition of NF-kB. Science 274, 784-787
DOI
ScienceOn
|
22 |
Wijayaratne, A.L., and McDonnell, D.P. (2001). The human estrogen Receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276, 35684-35692
DOI
ScienceOn
|
23 |
Kim, S.H., Lee, S.U., Kim, M.H., Kim, B.T., and Min, Y.K. (2005). Mitogenic estrogen metabolites alter the expression of 17betaestradiol- regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol. Cells 20, 378-384
|
24 |
Cantley, L.C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657
DOI
ScienceOn
|
25 |
Dubal, D.B., Rau, S.W., Shughrue, P.J., Zhu, H., Yu, J., Cashion, A.B., Suzuki, S., Gerhold, L.M., Bottner, M.B., Dubal, S.B., et al. (2006). Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 147, 3076-3084
DOI
ScienceOn
|
26 |
Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308
DOI
ScienceOn
|
27 |
Gupta, S. (2002). A decision between life and death during TNFalpha- induced signaling. J. Clin. Immunol. 22, 185-194
DOI
ScienceOn
|
28 |
Liu, Z.G. (2005). Molecular mechanism of TNF signaling and beyond. Cell Res. 15, 24-27
DOI
ScienceOn
|
29 |
Messmer, U.K., Pereda-Fernandez, C., Manderscheid, M., and Pfeilschifter, J. (2001). Dexamethasone inhibits TNF-alphainduced apoptosis and IAP protein downregulation in MCF-7 cells. Br. J. Pharmacol. 133, 467-476
DOI
ScienceOn
|
30 |
Wang, T.T., and Phang, J.M. (1995). Effects of estrogen on apoptotic pathways in human breast cancer line MCF-7. Cancer Res. 55, 2487-2489
|
31 |
Dowsett, M., and Ashworth, A. (2003). New biology of the oest rogen receptor. Lancet 362, 260-262
|
32 |
Lee, A.V., Cui, X., and Oesterreich, S. (2001). Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. Clin. Cancer Res. 7, 4429-4435
|
33 |
Burow, M.E., Weldon, C.B., Tang, Y., McLachlan, J.A., and Beckman, B.S. (2001). Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J. Steroid Biochem. Mol. Biol. 78, 409-418
|